Mississauga, Canada
MedAvail Technologies Inc., founded in 2012, is spearheading innovation in pharmacy technology. With headquarters in Canada, the company is primarily engaged in Biotechnology, Health Care, and Health and Wellness industries. Their flagship product, the MedCenter, is an automated dispensing and medication management system leveraging advanced robotics, two-way video teleconferencing, and secure patient medical information networks. This technology allows for pharmacist-controlled prescription dispensing, making it a significant asset for hospitals, pharmacies, and clinics.
MedAvail aims to revolutionize traditional pharmacy models by offering efficient and secure medication distribution. As of March 2023, the company attracted a $16.00M Post-IPO Equity investment, demonstrating investor confidence in its innovative approach. With its focus on transforming pharmacies through cutting-edge technology, MedAvail is well-positioned to capture a substantial share of the growing digital health market.
MDScripts
